There is a dearth of professionals with licenses and training to provide care for seniors’ mental and behavioral health challenges — such as Alzheimer's and other dementias, anxiety and depression. Seattle-based Rippl Care is seeking to change this. The startup just closed a $32 million seed funding round led by ARCH Venture Partners and General Catalyst.
Among the technologies represented by the group are medtech sensors tracking blood pressure, ostomy patient complications, tremor progression in Parkinson's disease patients, balance, cerebrospinal fluid levels, and more.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
NOCD recently closed a $33 million funding round, led by F-Prime Capital. The startup plans to reach more people with OCD to offer exposure and response prevention therapy, a type of therapy that is considered an effective treatment for OCD, but can be difficult to find.
The co-founders of the company include Hans Bishop, who founded Juno Therapeutics - one of the earliest commercial developers of CAR-T cell therapy technology - in 2013.
The Seattle-based company is one of several that have raised venture capital and equity investment funding this week.
The company, partnered with Beam Therapeutics, Verily Life Sciences and academic institutions, plans to use gene editing to tackle coronary artery disease. However, experience with gene therapy indicates cost could be a hurdle.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The company is developing means using CRISPR/Cas9 to edit genomes at the single-letter level, as opposed to the DNA- and RNA-cutting method usually employed.
The funding comes as competition for the Medicare population by startup and growth-stage companies intensifies, not only from other technology-led healthcare organizations like Iora but also from the likes of CVS Health and more established companies like CareMore.
Baltimore, Maryland-based startup Protenus has raised $11 million in a Series B round led by Kaiser Permanente Ventures and F-Prime Capital Partners. Arthur Ventures, LionBird Venture Capital and Cognosante Ventures also participated.
The funding will be used to expand the staff from 10 to 19 in the next 12 months and add to its customer base of hospitals and payers beyond Boston
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
WelbeHealth is taking advantage of a 2015 rule change by CMS to allow private, for-profit companies to support the Program for All-Inclusive Care for the Elderly (PACE).